CompletedPhase 2NCT01908205

Intranasal Oxytocin for the Treatment of Children and Adolescents With Autism Spectrum Disorders (ASD)

Studying Interatrial communication

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Holland Bloorview Kids Rehabilitation Hospital
Principal Investigator
Evdokia Anagnostou, M.D.
Holland Bloorview Kids Rehabilitation Hospital
Intervention
Intranasal Oxytocin(drug)
Enrollment
60 target
Eligibility
10-17 years · All sexes
Timeline
2013 – 2016

Study locations (2)

Collaborators

United States Department of Defense

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01908205 on ClinicalTrials.gov

Other trials for Interatrial communication

Additional recruiting or active studies for the same condition.

See all trials for Interatrial communication →

← Back to all trials